Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)
Investigation of Early Warning Signs for Blood Cancer Risk
Recruiting
40 years - 75 years
All
Phase
N/A
1 Location
Brief description of study.
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
The PROMISE study is the first study to test healthy people who may be at risk for early warnings signs of a blood cancer called multiple myeloma.
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Multiple myeloma is a type of blood cancer that occurs in the bone marrow. Before a person develops multiple myeloma, their marrow begins to make abnormal cells and proteins, which can be an early warning sign of the disease.
We're inviting qualifying adults with higher risks for multiple myeloma to participate in a screening study for early warning signs of the disease.
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
We will further study people who test positive for these early warning signs of multiple myeloma so that we can learn how to prevent them from developing into cancer.
Your participation may help researchers find new ways to prevent and treat blood cancer.
Detailed description of study
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
Normal
0
false
false
false
EN-US
X-NONE
X-NONE
How To Join and Get Screened for Free:
1. Take a short survey and decide whether to go to the next step.
2. Once you have completed the enrollment and are qualified for a free screening, we will send a collection kit to you at no cost.
3. When the kit arrives, it will contain instructions for how to schedule your free screening at a Quest Diagnostics lab near you where they will collect a small amount of blood.
4. We will check your blood sample for certain proteins that we call “precursor conditions for multiple myeloma.
5. We will notify all participants of their results.
This study investigates early warning signs of a blood cancer called multiple myeloma. Multiple myeloma is a type of cancer that begins in the bone marrow, where blood cells are made. Before developing multiple myeloma, a person's bone marrow might start producing abnormal cells and proteins, which can signal the onset of the disease.
The study involves a screening process for individuals at higher risk of developing multiple myeloma. Participants will first take a survey to determine eligibility. Those who qualify will receive a collection kit to schedule a free screening at a local lab. The lab will collect a small blood sample to check for proteins that indicate precursor conditions for multiple myeloma. All participants will be notified of their results.
Who can participate: Adults aged 40-75 who are African American or have a family member with multiple myeloma or related conditions like MGUS, Smoldering Multiple Myeloma, or Waldenström Macroglobulinemia are eligible.
Study details: Participants will take a survey to see if they qualify, and if eligible, receive a collection kit for a lab screening. The lab will collect a small blood sample to test for precursor conditions.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
